Construct: ORF TRCN0000467633
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF000728.1_s317c1
- Derived from:
- ccsbBroadEn_08191
- DNA Barcode:
- TGAACTCCATTTGGGGCGGGAACC
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- NTM (50863)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000467633
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 50863 | NTM | neurotrimin | NM_001144059.1 | 99.8% | 100% | 577A>C |
| 2 | human | 50863 | NTM | neurotrimin | XM_011542861.2 | 96.5% | 96% | (many diffs) |
| 3 | human | 50863 | NTM | neurotrimin | NM_016522.2 | 91% | 90.6% | (many diffs) |
| 4 | human | 50863 | NTM | neurotrimin | XM_017017865.2 | 90.8% | 87% | (many diffs) |
| 5 | human | 50863 | NTM | neurotrimin | NM_001144058.1 | 88.5% | 88.1% | (many diffs) |
| 6 | human | 50863 | NTM | neurotrimin | NM_001352004.1 | 88.3% | 87.9% | (many diffs) |
| 7 | human | 50863 | NTM | neurotrimin | NM_001048209.2 | 85.7% | 82.3% | (many diffs) |
| 8 | human | 50863 | NTM | neurotrimin | NM_001352002.1 | 85.7% | 85.2% | (many diffs) |
| 9 | human | 50863 | NTM | neurotrimin | NM_001352007.2 | 84.5% | 83% | (many diffs) |
| 10 | human | 50863 | NTM | neurotrimin | XM_017017862.2 | 84.5% | 83% | (many diffs) |
| 11 | human | 50863 | NTM | neurotrimin | XM_024448568.1 | 84.5% | 83% | (many diffs) |
| 12 | human | 50863 | NTM | neurotrimin | XM_017017854.1 | 84.2% | 83.9% | (many diffs) |
| 13 | human | 50863 | NTM | neurotrimin | XM_017017866.2 | 83.9% | 83.4% | (many diffs) |
| 14 | human | 50863 | NTM | neurotrimin | NM_001352005.2 | 83.5% | 80.1% | (many diffs) |
| 15 | human | 50863 | NTM | neurotrimin | NM_001352003.2 | 83.3% | 79.8% | (many diffs) |
| 16 | human | 50863 | NTM | neurotrimin | NM_001352008.1 | 82.9% | 82.4% | (many diffs) |
| 17 | human | 50863 | NTM | neurotrimin | NM_001352006.2 | 82.3% | 80.8% | (many diffs) |
| 18 | human | 50863 | NTM | neurotrimin | XM_017017858.2 | 82.3% | 80.8% | (many diffs) |
| 19 | human | 50863 | NTM | neurotrimin | XM_017017859.1 | 82.3% | 80.8% | (many diffs) |
| 20 | human | 50863 | NTM | neurotrimin | NM_001352001.2 | 80.9% | 77.5% | (many diffs) |
| 21 | human | 50863 | NTM | neurotrimin | XM_017017856.1 | 79.7% | 78.2% | (many diffs) |
| 22 | human | 50863 | NTM | neurotrimin | XM_017017857.2 | 79.7% | 78.2% | (many diffs) |
| 23 | human | 50863 | NTM | neurotrimin | XM_017017855.2 | 79.5% | 76.3% | (many diffs) |
| 24 | human | 50863 | NTM | neurotrimin | NM_001352009.2 | 79.1% | 78.7% | (many diffs) |
| 25 | human | 50863 | NTM | neurotrimin | XM_017017852.2 | 77.2% | 73.9% | (many diffs) |
| 26 | human | 50863 | NTM | neurotrimin | XM_024448569.1 | 76.9% | 76.6% | (many diffs) |
| 27 | human | 50863 | NTM | neurotrimin | XM_024448566.1 | 76% | 74.6% | (many diffs) |
| 28 | human | 50863 | NTM | neurotrimin | XM_024448567.1 | 74.5% | 74% | (many diffs) |
| 29 | human | 50863 | NTM | neurotrimin | XM_017017863.1 | 73.2% | 72.9% | (many diffs) |
| 30 | human | 50863 | NTM | neurotrimin | XM_017017860.2 | 71% | 70.6% | (many diffs) |
| 31 | human | 50863 | NTM | neurotrimin | XR_001747896.1 | 58% | (many diffs) | |
| 32 | human | 50863 | NTM | neurotrimin | NR_147850.2 | 31.1% | (many diffs) | |
| 33 | human | 50863 | NTM | neurotrimin | NR_147848.2 | 29.7% | (many diffs) | |
| 34 | human | 50863 | NTM | neurotrimin | NR_147853.1 | 26.9% | (many diffs) | |
| 35 | human | 50863 | NTM | neurotrimin | NR_147851.1 | 26.7% | (many diffs) | |
| 36 | human | 50863 | NTM | neurotrimin | XR_001747893.1 | 24.3% | (many diffs) | |
| 37 | human | 50863 | NTM | neurotrimin | NR_147849.2 | 23.9% | (many diffs) | |
| 38 | human | 50863 | NTM | neurotrimin | NR_147854.1 | 20.9% | (many diffs) | |
| 39 | human | 50863 | NTM | neurotrimin | NR_147852.1 | 20.1% | (many diffs) | |
| 40 | human | 50863 | NTM | neurotrimin | XR_001747894.2 | 16.1% | (many diffs) | |
| 41 | mouse | 235106 | Ntm | neurotrimin | XM_006510208.3 | 81.2% | 87% | (many diffs) |
| 42 | mouse | 235106 | Ntm | neurotrimin | XM_006510207.3 | 80.9% | 86.7% | (many diffs) |
| 43 | mouse | 235106 | Ntm | neurotrimin | XM_006510205.3 | 78.5% | 84.1% | (many diffs) |
| 44 | mouse | 235106 | Ntm | neurotrimin | NM_172290.3 | 78.4% | 81.1% | (many diffs) |
| 45 | mouse | 235106 | Ntm | neurotrimin | XM_017313304.1 | 76.3% | 79% | (many diffs) |
| 46 | mouse | 235106 | Ntm | neurotrimin | XM_017313305.1 | 76.1% | 78.7% | (many diffs) |
| 47 | mouse | 235106 | Ntm | neurotrimin | XM_017313306.1 | 75.5% | 81.6% | (many diffs) |
| 48 | mouse | 235106 | Ntm | neurotrimin | XM_006510206.3 | 73.9% | 76.4% | (many diffs) |
| 49 | mouse | 235106 | Ntm | neurotrimin | XM_006510209.3 | 71.1% | 76.8% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1014
- ORF length:
- 948
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 ttggcatggg ggtctgtggg tacctgttcc tgccctggaa gtgcctcgtg gtcgtgtctc 121 tcaggctgct gttccttgta cccacaggag tgcccgtgcg cagcggagat gccaccttcc 181 ccaaagctat ggacaacgtg acggtccggc agggggagag cgccaccctc aggtgcacta 241 ttgacaaccg ggtcacccgg gtggcctggc taaaccgcag caccatcctc tatgctggga 301 atgacaagtg gtgcctggat cctcgcgtgg tccttctgag caacacccaa acgcagtaca 361 gcatcgagat ccagaacgtg gatgtgtatg acgagggccc ttacacctgc tcggtgcaga 421 cagacaacca cccaaagacc tctagggtcc acctcattgt gcaagtatct cccaaaattg 481 tagagatttc ttcagatatc tccattaatg aagggaacaa tattagcctc acctgcatag 541 caactggtag accagagcct acggttactt ggagacacat ctctcccaaa gcggttggct 601 ttgtgagtga agacgaatac ttGGAAATTC AGGGCATCAC CCGGGAGCAG TCAGGGGACT 661 ACGAGTGCAG TGCCTCCAAT GACGTGGCCG CGCCCGTGGT ACGGAGAGTA AAGGTCACCG 721 TGAACTATCC ACCATACATT TCAGAAGCCA AGGGTACAGG TGTCCCCGTG GGACAAAAGG 781 GGACACTGCA GTGTGAAGCC TCAGCAGTCC CCTCAGCAGA ATTCCAGTGG TACAAGGATG 841 ACAAAAGACT GATTGAAGGA AAGAAAGGGG TGAAAGTGGA AAACAGACCT TTCCTCTCAA 901 AACTCATCTT CTTCAATGTC TCTGAACATG ACTATGGGAA CTACACTTGC GTGGCCTCCA 961 ACAAGCTGGG CCACACCAAT GCCAGCATCA TGCTATTTGG TGAGACTGTG CTCTGCCCAA 1021 CTTTCTTGTA CAAAGTGGTT GATATCGGTA AGCCTATCCC TAACCCTCTC CTCGGTCTCG 1081 ATTCTACGTA GTAATGAACT AGTCCGTAAC TTGAAAGTAT TTCGATTTCT TGGCTTTATA 1141 TATCTTGTGG AAAGGACGAT GAACTCCATT TGGGGCGGGA ACCACGCGTT AAGTCgacaa 1201 tcaacctctg gattacaaaa tttgtgaaag att